López HJF, Pérez ZMÁ, Aguilar RF

Language: Spanish
References: 25
Page: 177-181
PDF size: 121.81 Kb.

ABSTRACT

New and old antiepileptic drugs. Update. The prevalence of seizures in the pediatric population in Mexico is about 1.2%. The morbility and prevention the neurologic damage required of knowledge of classification from LICE rice in 1989. This information is important for early diagnosis and correct treatment. This information about new and old antiepileptic drugs colateral effects, interaction between new and old are important for better understanding of him problem in pediatric epileptic patients.

REFERENCES

1. Sherwin A. Ethosuximide. En: Elaine W, ed. The treatment of epilepsy principles and practice. Philadelphia-London: Lea and Febiger, 1993; 78: 923-31.

2. Remy C. Clobazam in the treatment of epilepsy. A review of the literature. Epilepsia 1994; (suppl. 5): S88-S91.

3. Schmidt D. Clobazam for treatment of intractable epilepsy: A critical assesment. Epilepsia 1994; (suppl. 5): S92-S95.

4. Dávila G, Mondragón A, Alcalá H. Utilidad del clobazam en el tratamiento de la epilepsia refractaria en nińos. Bol Med Hosp Infant Mex 1990; 47: 694-7.

5. Schmutz M, Brugger F, Gentsch C, MacLean M, Olpe H. Oxcarbazepine: Preclinical anticonvulsant, profile and putative mechanism of action. Epilepsia 1994; 33(suppl. 5): S47-S50.

6. Schwabe S. Oxcarbazepine: Clinical Development Program. Epilepsia 1994; 35(supp 5): S51-S53.

7. Friis M, Kristensen O, Dalby M, Deth SH, Gram L. Experiencias terapéuticas con 947 pacientes epilépticos ambulatorios en tratamiento con oxcarbazepina. Acta Neurol Scand 1993; 87: 224-7.

8. Blasie F, Bourgeois S. Felbamate in the treatment of partial-onset seizures. Epilepsia 1994; 35(suppl. 5): S58-S61.

9. Jensen P. Felbamate in the treatment of Lennox Gastaut syndrome. Epilepsia 1994; 35(suppl. 5): S54.-S57.

10. Herranz J, Pella V. Nuevos antiepilépticos: Vigabatrina, Lamotrigina, Felbamato. Rev Mex Pediat 1995; 62: 63-70.

11. Uldall P, Alving J, Gram L, Hogenhaven H. Vigabatrin in childhood epilepsy: A 5-year follow-up study. Neuropediatrics 1995; 25: 253-6.

12. Mumford J, Cannon D. Vigabatrin. Epilepsia 1994; 35(suppl. 5): S25-S28.

13. Arteaga R, Herranz J, Valdizan E, Armijo A. Gama-Vinyl GABA (Vigabatrin): Relationship between dosage, plasma concentrations, platelet GABA-transaminase Inhibition, and seizure reduction in epileptic children. Epilepsia 1992, 33: 923-31.

14. Yuen A. Lamotrigine: A Review of Antiepileptic Efficacy. Epilepsia 1994; 35(suppl. 5): S33-S36.

15. Schlurnberger E, Chavez F, Palacios L, Rey E, Pajot N. Lamotrigine in treatment. of 120 children with epilepsy. Epilepsia 1994; 35: 359-67.

16. Richens A. Safety of Lamotrigine. Epilepsia 1994; 35(suppl. 5): S37-S39.

17. Brodie M. Lamotrigine versus other antiepileptic drugs: A star reating system is born. Epilepsia 1994; 35(.suppl. 5): S41-S49.

18. Leiderman D. Gabapentin as add-on therapy for refractory partial epilepsy results of five placebo- controlled trials. Epilepsla 1994; 35(suppl 5): S74-S76.

19. Fromm G. Gabapentin: Discussion. Epilepsia 1994; 35(suppl. 5): S77-S79.

20. Lee D, Steingard Cesena N, Helmers L, Riviello J. Behavioral side effects of Gabapentin in Children. Epilepsia 1996; 37: 87-90.

21. Illum N, Taudorf K, Heilman C, Snith T, Mansa B. Intravenous inmunoglobulln: A single blind trial in children with Lennox Gastaut syndrome. Neuropediatrics 1990; 21: 87-90.

22. Arali JA, Fontana A. Immunological aspects of epilepsy. Epilepsia 1980; 21: 451-7.

23. Gross-Tsur B, Shalev RS, Kasir E, Engelhard D. Intravenous high dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand 1993; 88: 204-10.

24. Aguilar F, González R, Ramírez N. Tratamiento del síndrome de Lennox-Gastaut con gammaglobulina intravenosa. Bol Med Hosp Infant Mex 1996; 53: 341-8.

25. Dichter M, Brodie M. New antiepileptics drugs. N Engl J Med 1996; 1583-90.